Mirtazapine Tablet, Film Coated
Product Images NDC 72603-558

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 72603-558). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (7.5 mg (30 Tablet Bottle))

Package Label-principal Display Panel (7.5 mg (30 Tablet Bottle))
Mirtazapine Tablets USP 7.5 mg film-coated tablets label from NorthStar Rx LLC. The label indicates a 30-tablet count, includes storage instructions, manufacturer details (APL Healthcare Limited, India), and states the product is made in India. The label also features the NDC 72603-558 and emphasizes dispensing with a medication guide.*
FDA Label Image

Chemical Structure (Mirtazapine Str)

Chemical Structure (Mirtazapine Str)
Chemical structure of Mirtazapine, showing its molecular framework with nitrogen and carbon rings and a methyl group attached.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.